Lilly, BMS win broader use of Erbitux in head and neck cancer
08 November 2011
Donna Young
Please Login to read the full article.
08 November 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- Iron chelator, prostate cancer conundrum on deck for ODAC
- US Capitol Capsule: Hope not enough for Avastin in MBC; Hamburg explains withdrawal
- ODAC backs ApoPharma's iron chelator, but lacks harmony on prostate cancer trials
- Data for Roche, BMS melanoma drugs stir excitement at ASCO
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
